Showing results (41-50 of 472) with videos related to
Sort By:
Pageof 48
Therapeutic Advances in Cardiovascular Disease|March 27, 2015
Early glucose variability in cardiogenic shock following acute myocardial infarction: a pilot studyChiara Lazzeri, Serafina Valente, Marco Chiostri, et al.Therapeutic Advances in Cardiovascular Disease|March 29, 2021
The dawn of the four-drug era? SGLT2 inhibition in heart failure with reduced ejection fractionMichael V Genuardi, Paul J MatherTherapeutic Advances in Cardiovascular Disease|July 8, 2020
Flecainide is well-tolerated and effective in patient with atrial fibrillation at 12 months: a retrospective studyMikayla Muzzey, Katie B Tellor, Karthik Ramaswamy, et al.Therapeutic Advances in Cardiovascular Disease|April 4, 2015
Patients with biopsy-proven nephrosclerosis and moderately impaired renal function have a higher risk for cardiovascular disease: 15 years' experience in a single, kidney disease centerHiromichi Suzuki, Kazuhio Kobayashi, Yuji Ishida, et al.Therapeutic Advances in Cardiovascular Disease|April 24, 2023
Identification of biomarkers, pathways, and potential therapeutic targets for heart failure using next-generation sequencing data and bioinformatics analysisPrashanth Ganekal, Basavaraj Vastrad, Chanabasayya Vastrad, et al.Therapeutic Advances in Cardiovascular Disease|January 7, 2009
Pre-eclampsia: the pivotal role of the placenta in its pathophysiology and markers for early detectionAmret Hawfield, Barry I FreedmanTherapeutic Advances in Cardiovascular Disease|January 7, 2009
Effects of alcohol on atrial fibrillation: myths and truthsCarlos E B Balbão, Angelo A V de Paola, Guilherme FenelonTherapeutic Advances in Cardiovascular Disease|January 7, 2009
Renin-angiotensin-aldosterone system intervention in the cardiometabolic syndrome and cardio-renal protectionAdam Whaley-Connell, Brian S Pavey, Kunal Chaudhary, et al.Therapeutic Advances in Cardiovascular Disease|January 7, 2009
Genetics of the cardiometabolic syndrome: new insights and therapeutic implicationsSilvia Sookoian, Carlos J PirolaTherapeutic Advances in Cardiovascular Disease|January 7, 2009
HMG CoA reductase inhibitors and renoprotection: the weight of the evidenceL Romayne Kurukulasuriya, Ganesh Athappan, Georges Saab, et al.Pageof 48